1-215780013-G-A
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_206933.4(USH2A):c.10769C>T(p.Pro3590Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000781 in 1,614,062 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P3590P) has been classified as Likely benign.
Frequency
Consequence
NM_206933.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000565 AC: 86AN: 152088Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000621 AC: 156AN: 251166Hom.: 2 AF XY: 0.000508 AC XY: 69AN XY: 135724
GnomAD4 exome AF: 0.000804 AC: 1175AN: 1461856Hom.: 0 Cov.: 32 AF XY: 0.000771 AC XY: 561AN XY: 727222
GnomAD4 genome AF: 0.000565 AC: 86AN: 152206Hom.: 1 Cov.: 33 AF XY: 0.000605 AC XY: 45AN XY: 74404
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:4
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 22, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2017 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Usher syndrome type 2A Uncertain:1Benign:1
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | May 03, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Apr 30, 2019 | This variant was classified as: Uncertain significance. The following ACMG criteria were applied in classifying this variant: PP3. - |
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 13, 2010 | Pro3590Leu in exon 55 of USH2A: This variant is not expected to have clinical si gnificance because Pro3590 is not conserved among closely related species with R at having a Leucine (Leu) at this position. In addition, this variant was found occur at an equal frequency between probands and a control population (Dreyer 20 08). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at